Infermedica 2020: Year in Review
Discover what happened at Infermedica in the past months and how it led us to support global healthcare despite the challenges of 2020.
Infermedica raises $10.25M in Series A funding
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Infermedica raises $3.65M in a new round of funding
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.
Infermedica 2018: Year in Review
With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.
We’ve moved Symptomate to the next level
Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.